Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2025-04-17 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
拟续聘2024年度会计师事务所公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm for the 2025 fiscal year. It details the accounting firm's background, audit fees, and the board and audit committee's approval process. It does not contain any actual financial statements or audit results, but rather information about the appointment process and related approvals. The document length is 2913 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates to audit services and auditor appointment, but it is not the audit report itself. However, given the document is primarily an announcement of auditor reappointment and related information, it fits best under AR (Audit Report / Information) rather than a full Annual Report or Regulatory Filing. Confidence is high due to clear content focus on audit firm reappointment and audit service details. FY 2025
2025-04-17 Chinese
2024年度独立董事述职报告（聂采现）
Board/Management Information Classification · 95% confidence The document is titled as the "2024年度独立董事述职报告" which translates to "2024 Annual Independent Director's Work Report." It details the independent director's attendance at board and shareholder meetings, communication with internal audit and accounting firms, supervision of company operations, protection of investor rights, and training activities during the year 2024. The content is a detailed report on the independent director's duties and activities over the year, rather than an announcement or a brief summary. It does not contain financial statements or audit results, so it is not an Annual Report (10-K) or Audit Report (AR). It is not a regulatory filing or certification letter. The document is a management-related report focusing on the independent director's role and activities, which fits best under Board/Management Information (MANG).
2025-04-17 Chinese
会计师事务所关于四川千里倍益康医疗科技股份有限公司2024年度募集资金存放与使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "募集资金年度存放与使用情况鉴证报告" which translates to "Annual Verification Report on the Deposit and Use of Raised Funds" for the year 2024. It includes detailed financial data about the raised funds, their usage, balances, and related audit verification by a certified public accountant firm. The document is not a full annual report but a specialized audit/verification report focusing on the use and management of raised capital funds. It contains substantive financial data and audit opinions related to the raised funds, which fits the definition of an Audit Report / Information (AR). It is not a general annual report (10-K), nor a simple announcement or presentation. The length and detail confirm it is the report itself, not just an announcement. Therefore, the correct classification is AR with high confidence.
2025-04-17 Chinese
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a public stock issuance by Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It includes specifics on the amount raised, timing, usage, balance, investment projects, changes in fund usage, and compliance with regulatory requirements. It also contains verification opinions from the sponsoring institution and an accounting firm. The document is titled as a "专项报告" (special report) on the storage and actual use of raised funds, which aligns with a capital/financing update rather than a full annual or interim financial report. It is not an announcement of a report publication but the report itself, given its length (9079 characters) and detailed content. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-04-17 Chinese
2024年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a notice announcing the convening of the 2024 Annual General Meeting (AGM) of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the meeting date, voting methods, agenda items to be discussed, and procedural information for shareholders. It does not contain the actual annual report or financial statements but references where those reports can be found. The document is under 5,000 characters and serves as an announcement for the AGM, not the report itself. Therefore, it fits the category of AGM Information (AGM-R).
2025-04-17 Chinese
董事会审计委员会2024年度履职情况报告
Board/Management Information Classification · 95% confidence The document is titled as the "2024年度履职情况报告" (2024 Annual Performance Report) of the Board Audit Committee of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the audit committee's activities, meetings, evaluations of the external auditor, and overall performance during the year 2024. The content focuses on the audit committee's work and oversight rather than presenting full financial statements or audit opinions themselves. It is not a standalone audit report (AR) nor a full annual report (10-K). Instead, it is a report on the audit committee's duties and performance, which fits best under Board/Management Information (MANG) as it relates to board committee activities and governance oversight. The document length is 2585 characters, which is relatively short and focused on committee activities rather than full financial disclosures. Therefore, the most appropriate classification is MANG with high confidence.
2025-04-17 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.